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Lead in Bone: Implications for Toxicology
during Pregnancy and Lactation
by E. K. Silbergeld*
Advances in understanding the distribution and retention of lead in mineralized tissues are im-
portant for two reasons: first, bone lead may be a more accurate dosimeter ofintegrated absorption
associatedwith chronicexposures, and second, bonelead maybe a source ofinternal exposure to the
host organism. Little attention has been paid to this second aspect, the remobilization oflead from
bone. Mobilization ofleadfrom bone islikely to occur duringperiods ofaltered mineral metabolism;
since calciotropic factors determine the uptake and storage oflead in this compartment, changes in
calcium-related regulatory factors are likely to affect lead compartmentation. Calcium metabolism
changes drastically in humans during pregnancy and lactation; although relatively little is known
oflead kinetics during these critical periods, it is likely that bone lead is mobilized and transferred
tothe morebioavailable compartment ofthematernal circulation, withpotential toxiceffectsonthe
fetus and the mother.
Introduction
The title ofthis conference, "Lead in Bone, Implica-
tions for Dosimetry and Toxicology," examines two op-
portunitiespresentedby the ability to measure lead in
bone. The first opportunity is the improvement in
evaluating lead dose, particularly chronic, integrated
dose, or the influx oflead into bone. The second oppor-
tunity is the ability to study lead in bone as a source
of internal lead exposure, or the efflux of lead from
bone. Understanding the effects of lead on reproduc-
tion will be advanced by using bone lead measure-
ments for both influx and efflux oflead into this com-
partment.
The effects of lead on fetal growth, intrauterine de-
velopment, andpostnatal statushave longbeen ofcon-
cern in occupational and environmental medicine.
More recently, several large epidemiological studies
have reported deficits in early infant development ob-
served in children born to mothers whose blood lead
levels during pregnancy were only slightly elevated as
comparedto acontrol group(1-3). Becausethese expos-
ures, as measured by blood lead, fall within the range
found in much ofthe population ofthe United States,
the findings have implications for defining perinatal
lead toxicity as an epidemic (4). Further definition of
dose response and understanding ofcritical time peri-
ods during pre- and postnatal development for the
neurotoxic effects oflead are critical for designing ap-
propriate screening and intervention. The data cur-
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rently available do not clearly separate the effects of
prenatal exposure from those of postnatal exposure,
particularly in terms ofrelative persistence.
The two large-scale prospective studies on lead ex-
posure in the U.S. (1,2) and the prospective study un-
derway in Yugoslavia (5), may provide data that will
help to definethese issues. Atpresent, the resultsfrom
the Cincinnati study (2) have been interpreted to sup-
port a hypothesis that prenatal lead exposure results
in more persistent deficits inbehavior than does early
postnatal exposure, while the Boston study (1) results
appear to support the opposite hypothesis.
A complication in interpreting these studies lies in
major uncertainties concerning lead toxicokinetics
during pregnancy. The most commonly used marker
for lead exposure is the measurement oflead inblood,
which is a useful indicator of relatively recent or
steady-state lead exposure given that the half-life of
lead inthis compartment is only 35 days(6). The inter-
pretation ofthese studies is based on the assumption
that blood lead levels usually measured once, at deliv-
ery, accurately reflect exposure ofthe mother and the
fetus over pregnancy. However, blood levels change
over pregnancy, and lead is rapidly transferred across
the placenta to the fetus (7).
To evaluate fully the significance offetal lead expos-
ure, it iscritical to knowthe determinants offetal lead
dose. Total fetal dose reflects not only the transfer of
lead derived from mother to fetus associated with the
mother's exposures during her pregnancy but also the
transfer oflead stored inthe mother accumulated over
her prior history of lead exposure.
In addition, the mobilization oflead from bone dur-
ing pregnancy and lactation may have toxic effectsE. K. SILBERGELD
upon the mother. Lead toxicity must reflect the phar-
macodynamic interactions oflead with its intracellu-
lar sites of toxic action; the more frequently and in-
tensively atoms of lead pass by these receptors, the
more likely cell and organ level toxicity will be pro-
duced. Fromthe perspective ofthe receptor, a recycled
atom of lead is the same as a newly absorbed atom.
Mobilizationofboneleadintothecirculation increases
the amount of lead in the proximately bioavailable
compartment ofthe plasma.
This paper will discuss evidence for the hypothesis
that mobilization of maternal lead stores occurs dur-
ing pregnancy and that this mobilization is an impor-
tantfactorinoverallfetal exposure andpotential toxic
effects toboth mother and fetus. Although the focus of
this paper is on maternal-fetal leadtoxicokinetics and
toxicity, itis not meanttoimplythatthese aretheonly
effects ofsignificance related to lead and perinatal de-
velopment. Male-mediated exposures and effects of
lead on male reproduction are not considered in this
paper, but may well be ofimportance in assessing the
overall significance ofrelatively low-level lead expos-
ures on reproduction and child development.
The paperwill review available data onleadkinetics
duringpregnancy andlactation fromboth clinical and
experimental studiesandthefewcase studiesofeffects
observed in mothers and children. It will also review
what is known of mineral metabolism during preg-
nancy sincethefactorsregulatingmineralmetabolism
thatrespondtothe physiological andhormonal chang-
es during these periods also affect lead storage and
bioavailability.
Lead Toxicokinetics during
Pregnancy and Lactation
Human Data
Our information onthe toxicokinetics oflead during
pregnancy is indirect. As noted by Miller (8), kinetic
studies inpregnancy mustaccountforcomplexinterre-
lationshipsinvolvingthreecompartments: themother,
the fetus, and the placenta. For studies involving post-
natal exposure via lactation, the child and the addi-
tional compartment ofbreastmilkmustbe included. In
clinical studies, these three compartments are not
readily available at the same time for sampling and
analysis. Unfortunately, inmostexperimental studies,
these compartments have not been studied in an inte-
grated manner.
For lead, within humans, both mother and fetus,
there are several compartments ofkinetic importance:
blood, soft tissue, and bone (9). As discussed by Rabin-
owitz(6),each ofthesecompartments mayhave several
bindingandstorage siteswith internalfluxesthatreg-
ulate overall intercompartmental fluxes andeventual-
ly maternal-fetal lead kinetics.
Two types of studies of maternal blood lead levels
havebeenconductedduringpregnancy: cross-sectional
andlongitudinal. Thecross-sectional studies ofwomen
atdifferent stagesofpregnancy show atendencyforde-
creased blood lead from the first to second trimester
andrelativelylittlechangethereafter(10,11). However,
these cross-sectional studies may be confounded by
age, which is a significant factor in determining blood
lead levels and which may influence mineral metabo-
lism (see below). The longitudinal studies, following
cohorts over pregnancy, have not shown clear trends
(12,13). Studies of blood lead at delivery, based upon
sampling fetal blood from the umbilical cord, indicate
that lead is readily transferred across the placenta.
The correlations between maternal blood lead levels
and those in cord blood are almost 1.0 (5).
Lead absorption and retentionby the fetus has been
extensively studied by Barltrop (12). He found signifi-
cant increases in lead content (but not concentration)
infetal bone and organs over gestation. A more recent
study concluded that lead did not accumulate in hu-
manfetusesduringthefirsttrimester(14),whichisnot
inconsistent with what is known of mineral metabol-
ism over pregnancy (see below).
Two case studies provide evidence that there can be
significantmobilizationofleadfrombone duringpreg-
nancy. One case study suggests that the mobilization
oflead during pregnancy can result in relatively high-
dose exposure with overt toxicological consequences
for the infant (15). Over the course of pregnancy, one
woman'sbloodleadlevels increaseddramaticallyto 74
,ug/dL, with clinical signs ofintoxication and her baby's
blood lead level was 55 1tg/dL. There was no evidence
ofincreasedexposuretoexternal lead sources overthis
period of time. The authors determined that she had
had excessive lead exposure as a young child, over 30
years prior to this pregnancy.
In another case study, Manton measured his wife's
blood lead and speciated it by stable isotopic ratio. He
reported changes in stable isotopic ratios that indi-
cated contributions to blood lead over pregnancy from
a pool that did not correspond tothe external source of
lead at the time of measurement (16).
We have investigated changes in bone lead stores
somewhat more directly by using the NHANES II
dataset (17). In a group ofpostmenopausal women, we
found significant increases in blood lead concentra-
tions ascomparedtopremenopausal women, after con-
trolling for age, calcium intake, and other variables
potentially related toboth external lead exposure and
mineral metabolism (Table 1). Of relevance to this
topic, we also found that in postmenopausal women
who had ever been pregnant, the extent of the post-
menopausal increase in blood lead was significantly
less than that in nulliparous postmenopausal women
(Fig. 1). These data suggestthatduringprior pregnan-
cies (and possible lactation), there was some mobiliza-
tionofbone leadsuchthatlesswassubsequently avail-
able for mobilization during demineralization after
menopause. Alternatively, nulliparous women may be
more at risk for postmenopausal bone demineraliza-
tion, although epidemiological studies of postmeno-
pausal osteoporosis have not clearly shown this (18).
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Thble 1. Variables entered in univariate
and multivariate analyses.
Lead-related variables
Age (in years)
Age squared
Racea
Incomeb
Degree ofurbanizationC
Lead used in gasoline (108 g/day)
Number ofcigarettes per day
Alcohol drinker (greater than one drink/week)
Variables related to osteoporosis
Dietary calcium (mg/day)
Hypertensive medication
Body mass indexd
Subscapular skinfold (cm)
Dietary phosphorus (g/day)
Dietary protein (g/day)
Tricep skinfold (cm)
Recreational exercisee
Hypothesis variables
Menopause status
Years since menopause
Pregnancy history
Race
a 1 = black, otherwise 0.
b 1 = less than $5000/year; 2 = $5000-15,000/year;
3 = $15,000/year.
c 1 = cities over 3,000,000 to 8 = rural under 2500.
d Weight/height2.
e 1 = little or none; 2 = moderate; 3 = heavy.
-
a
I
0
All Womn Premeno Postmno Postmno
(n-46) (n-305) (n-541) null pera
(n-54)
Postwno
pare
(n-487)
FIGURE 1. Blood lead concentrations in black and white women,
aged 40 to 60 years (n = numbers in sample used for analysis).
Premeno, premenopausal women; postmeno, postmenopausal
women; postmeno null para, postmenopausal women with no
prior pregnancies; postmeno para, postmenopausal women with
at least one pregnancy. Data from NHANES II survey; see Sil-
bergeld et al. (17)for details ofanalyses.
Lead is also secreted in breastmilk in a range from
0.24 to 35 mcg/dL. External exposures influence
breastmilk lead levels, as expected, such that urban
populations in general have higher levels than rural
populations (19). Lead is found in concentrations
higher than those found in plasma at the same time
(20). Breastmilkleadconcentrationsmayincreaseover
lactation, although no comprehensive studies have
beendone. Womenolderthan 30yearshadsignificant-
ly higher levels of breastmilk lead than women be-
tween 20 and 30 years ofage (11). This may reflect the
generalincreaseinstoredandcirculatinglevelsoflead
asafunctionofageoralteredmineralmetabolismdur-
ing lactation in older women.
Experimental Data
Only a few studies ofexperimental animals exposed
to lead have examined lead kinetics over pregnancy.
These studies are further limited in interpretationbe-
cause of incomplete design and because rodents may
notbeadequatemodelsforthephysiologyofpregnancy
in humans. These studies have confirmed that lead is
rapidly transferred from mother to fetus, particularly
during the late stages of gestation. Moreover, after
midgestation in the rodent, the flux oflead from ma-
ternaltofetalcirculationfavorstheplacental andfetal
compartments (21). Totalfetal leadcontent ofthe fetus
increased with time but concentration tends to de-
crease [as notedby Barltrop inhumans(12)]because of
the relatively greater rate offetal growth during this
period.
Two experimental studies have examinedthe poten-
tial for redistribution of lead from the mother to the
fetus and infant during pregnancy and lactation.
Buchet et al. (22)foundthat in rats exposedto leadfor
150days, whose exposure wasthendiscontinuedfor 50
dayspriortomating, there was a substantial mobiliza-
tion of lead from mother to fetus. This transfer was
more pronounced inthe di- continuous exposure group
than in groups in which lead exposure was continued
up to or through gestation, which the authors inter-
preted to reflect differences in bone resorption rather
than lead dosage.
Keller and Doherty(23)examined leadkineticswith
radiotracer lead (210Pb) in female rats over gestation
andlactation. Theyfoundthatthemajorperiodofbone
lead mobilization occurred during lactation rather
than gestation. This involved both the lead adminis-
teredtolactatingmothers andthe mobilization oflead
stored in maternal bone from prior exposure. This lat-
ter source of lead transfer from maternal bone paral-
leled the measured decrease in bone mineral content
over the same period. However, not all this lead was
transferred to the sucking infant via milk; maternal
excretion oflead was also increased during lactation.
Because ofthe relative lack ofclinical data and un-
availabilityofinformationfromprimatemodelsoflead
toxicokinetics during these periods, interpretation of
these results mustbe guarded. It is appropriate to con-
clude that there is evidence that lead metabolism
changes during pregnancy and lactation and that the
transfer oflead to the fetus and neonate is likely to be
enhanced.
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FIGURE 2. Calcium metabolism in early pregnancy. A major physio-
logical change influencing calcium metabolism is the increase in
maternal blood volume during this period; as a consequence, in
order to maintain circulating levels ofcalcium, total calcium in
the blood compartment is increased primarily through increas-
ingintestinal calcium absorption and reducing renal calcium ex-
cretion. It is also possible that the decreased production ofestro-
gen in pregnancy affects bone cell status through estrogen recep-
tors in a manner similar to that observed in postmenopausal
osteoporosis, that is, to increase bone resorption. The major hor-
monal signals governing these changes are parathyroid hor-
mone and 1,25-dihydroxyvitamin D, both ofwhich are increased
in the circulation.
Mineral Metabolism during
Pregnancy and Lactation
Pregnancy and lactation place significant demands
on the availability of calcium from the diet and from
physiological stores in mineralized tissue (24,25). As
shown inFigures 2 and3, during pregnancy, two major
changes affect calcium physiology: first, blood volume
significantly increases, which requires increased cir-
culating calcium to maintain normal [Ca2+], and sec-
ond, the fetus exerts a demand for calcium for ossifica-
tion and growth. This second requirement for calcium
is greatest during the third trimester when the fetus
obtains about 20 g of the total intrauterine require-
mentof30 gofcalcium(25,26). Duringlactation, an ad-
ditional and even greater demand is placed upon ma-
ternal sources of calcium for the secretion of this
essential mineral in breast milk (Fig. 4). These de-
mands of the developing organism and mother have
only two possible sources of supply: increased dietary
sources through a change in diet and enhanced reten-
tion of exogenously derived calcium, or a draw upon
calcium inbone through the modification ofbone turn-
over to favor resorption. During pregnancy, however,
along with increased calcium absorption (about twice
normal levels), calcium excretion is also increased(24).
Fetal Ca+ requirement
11,25-(OH)2VITAMIN D a intestinal Ca' absorption
BONE 4 4maternal blood [Ca++]
_- PROLACTIN
FIGURE 3. Calcium metabolism in late pregnancy (third trimester).
During this period, fetal ossification becomes a driving factor in
altering maternal calcium metabolism. Calcium is supplied to
thefetus, andmaternal calcium metabolism isregulatedby vita-
min D, parathyroid hormone, and prolactin.
LACTATION
PRL
Ca" secretion in milk
| maternal blood [CaJ*]
1 'tintestinal Ca' absorption
BONE PTH 1,25-(OH)2VITAMIN D
FIGURE 4. Calcium metabolism during lactation. During this peri-
od, the stress on maternal calcium metabolism is qualitatively
greatest, and the extent ofbone demineralization is potentially
the largest. Prolactin, parathyroid hormone, and vitamin D all
regulate changes in calcium metabolism during lactation.
Calcium requirements for pregnant and lactating
women are much greater than those for adult men.
During the last trimester, the fetus retains about 250
mg ofcalcium per day, generating a maternal daily in-
take requirement ofabout 1100 mg/day. During lacta-
tion, about 400 and 1600 mg/day is secreted in breast-
milk each day (24). The recommended daily intake of
calcium is even greater, about 1300 mg/day (25). At
this time, both calcium absorption increases and cal-
cium is drawn from bone stores.
However,there is still some controversy over calcium
EARLY PREGNANCY
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requirements during pregnancy. It has been assumed
that adequate dietary intake ofcalcium will prevent
demineralization of maternal bone (25). However, the
clinical data are still incomplete, in that many studies
werenotcontrolledforcalciumintake ormeasurement
ofcalcium balance. Physiologically, maternal metabo-
lism adapts during pregnancy to exploit both external
and internal sources of calcium. Dietary calcium is
conservedby increasing gut absorption ofcalcium and
decreasing renal excretion. Hormonal changes are the
major factors controlling these adaptations. There is a
steady and significant increase in circulating levels of
1,25-dihydroxyvitamin D duringpregnancy in humans
(27,28) and circulating levels ofparathyroid hormone
may also be increased (24). Prolactin is another major
hormonal mechanismformodifyingcalciummetabolism
during pregnancy and lactation, increasing calcium
absorption and placental transfer of calcium (29,30).
However, inmanypregnantandlactatingwomen,bone
maybe anadditional source ofcalcium as evidencedby
changes in bone formation rate, loss ofbone mineral,
and frank osteoporosis in some cases (31,32). Some
studieshavefoundasmuch as 10%lossofbonemineral
in lactating women whose diets were only somewhat
calcium deficient (about 900 mg/day)(33). In rats with
adequate calcium and vitamin D intake, between 15
and 40% ofbone mineral can be lost during lactation
(34).
More detailed studies have demonstrated the com-
plexity of bone physiology during pregnancy (Figs. 2
and 3). Purdie et al. (35)reported increased rates ofre-
sorption in early pregnancy, followed by increased
rates of formation in late pregnancy, a finding paral-
leled by experimental studies in rats (34). This bipha-
sic change inbone mineral status, which may result in
part from changes in circulating estrogen levels could
reflect a storage mechanism to provide calcium for the
greater demands of lactation (Fig. 4). There is also
some suggestion that different parts ofbone are differ-
entially mobilized during different phases ofbone re-
sorption, which may be of importance in estimating
relative availability ofleadstoredinspecificregionsor
types ofbone (36).
Important Factors in Bone Lead
Mobilization
It seems reasonable to conclude that bone lead is a
potential source oflead for the fetus and neonate and
thatthe kinetics oflead inbone follow those ofcalcium
inbone during the periods ofpregnancy and lactation.
Ifthisisthecase, itisimportanttodeterminethosefac-
torsmodulatingthe movement ofleadfrombone inhu-
man pregnancy. Some of these factors are discussed
below.
Lead Exposure. Integrated, cumulative lead expo-
sure is obviously important in determining fetal and
neonatal exposure from both stored lead and concur-
rent external exposures (7). Also, the dose rate oflead
exposure mayinfluencethelocation andconcentration
oflead in bone and its later availability for mobiliza-
tion, as suggested by Rabinowitz (6).
MaternalAge. Inadditionto determiningbody lead
burden and concentrations in bone, maternal age may
influence mineral metabolism. Adolescent mothers
with inadequate calcium metabolism have relatively
high bone loss during lactation (33). Given the preva-
lence ofdietary deficiencies inthis population andthe
increasing rate ofpregnancy among adolescents, par-
ticularly in groups athighriskforenvironmental lead
exposure (37), the coincidence ofthese two highly cor-
related factors, age and nutrition, may be very impor-
tant for lead exposure. In another age-related observa-
tion, older women appear to secrete higher levels of
lead in breastmilk than do younger women, but this
may reflect general trends in lead exposure and body
lead burden.
GestationalAge. Gestationalageclearlyinfluences
mineral metabolism in both mother and fetus. The
fetus produces 1,25-dihydroxyvitamin D and hence
regulates its own active calciumuptake acrossthe pla-
centa (26,38). The most active phase ofcalcium trans-
fer to the fetus occurs in the last trimester of preg-
nancy, a period that coincides with the critical phases
ofneurodevelopment in which synaptogenesis and ar-
borization ofthe cortex andcerebellum occur(39). This
coincidenceisunfortunatebecause oftheeffectsoflead
to inhibit synaptic formation (40) and to block neuro-
transmitter-directed cytoarchitectural development of
the brain (41).
MaternalNutritional Status. As noted above, ma-
ternal nutrition is a major determinant of maternal
mineral metabolism during pregnancy and lactation.
Calcium- and vitamin D-deficient diets during these
periods result in substantial bone demineralization
(33). Maternalnutritional statuswillalsoaffecttheab-
sorption and retention oflead; although it is not clear
that supplementing the diet with calcium can reduce
lead absorption or affect lead kinetics, deficiencies
clearly enhance the absorption of lead (42).
Parity. Little is known ofthe influence ofnumber of
pregnancies upon maternal mineral metabolism. In
epidemiological studies, parity number is confounded
by age and weight, variables that also affect mineral
physiology (43). We found that parity influenced the
magnitude ofpostmenopausal increases in blood lead
levels (17), as discussed above, but we could not ex-
amine the impact of number of pregnancies due to
small sample size available for analysis of this vari-
able. Parity is a complex variable in studies of post-
menopausal osteoporosis, and number ofpregnancies
aswell asage atpregnancy areimportant,althoughin-
completely understood, factors (18).
Race. For demographic and socioeconomic reasons
primarily, race is a determinant of lead exposure in
American populations (37). Nutritional status also
varieswithrace intheU.S., andcalcium-deficientdiets
are more common among poor, disadvantaged minor-
itywomenthan amongother groups. Race isalso a var-
iable in mineral metabolism, with black women ex-
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periencing much lower incidence of postmenopausal
osteoporosisthanwhitewomen(18). Wefoundasignifi-
cant difference between white andblack women inthe
relative increase in blood lead levels following meno-
pause, consistent withadecreased lossofbone mineral
in black women. Among Asian and Turkish women,
osteomalacia has been diagnosed during and after
pregnancyofsufficient severity to increasetherisks of
fracturesduringpregnancy andricketsintheirinfants
(44). Thiscondition maybe duetoinadequate intake of
vitamin D in these populations and hence to socio-
economic and cultural factors rather than genetics.
Summary and Research Needs
This conference has focused on bone lead primarily
as an improved dosimeter for determining cumulative
leadexposure inspecific groups atrisk, primarily chil-
dren and workers. However, given the lability ofbone
mineral stores, there are additional toxicological con-
cerns about the potential for release oflead from bone
stores during normal physiological conditions that
increase bone mineral loss. Of major importance for
publichealthisthepotential mobilization ofleadfrom
bone during pregnancy and lactation, with potential
toxic consequences for both the mother and the
neonate.
Most attention has been paid to the potential expo-
sure of the fetus; however, the remobilization of lead
during pregnancy and lactation may have toxic conse-
quences for the mother as well, as lead is returned to
thebioavailable compartment(plasma)andmaybe re-
distributed to such target organs as brain, heart, and
kidney.
The available data are sparse. Some experimental
data confirm that both dietary and stored lead are
transferred tothe fetus avidly and that maternal bone
stores of lead may be mobilized, particularly during
lactation. In humans, there is at least one case ofma-
ternal intoxication during pregnancy due to mobiliza-
tion of significant bone lead stores (15). Indirect evi-
dence for such mobilization was also found in a large
population-based survey of the U.S. population, in
which postmenopausal women were found to have sig-
nificant increases in blood lead, but this increase was
diminished by prior pregnancy (17).
Ifbone lead stores are a potential source oflead for
the fetus, there are several important implications for
the medical management of lead exposure and inter-
vention aswell as needed areas for research. First, the
possible contribution ofprior lead exposure, resulting
in increased bone lead, must be evaluated in epidemi-
ological studies associating lead dose with outcome in
infants and young children. Second, the prior history
of lead exposure may be important to determine in
evaluating individuals andpopulations at risk. Third,
determinants ofbone status during pregnancy may be
important not only for preventing osteomalacia, hypo-
calcinemia, hyperphosphatemia, and other mineral-
related problems ofpregnancy and the fetus, but also
to prevent untoward mobilization of lead from bone.
Fourth, methods for determining the overall toxico-
kineticsofleadduringpregnancy, particularlytheflux
oflead from bone to the fetus, must be developed.
There is a consensus as to the research needed in
order to develop feasible implementation ofbone lead
measurements for better estimation oflead dose-the
influx term (36). For the purpose ofestimating poten-
tial exposure tobone lead-the effluxterm-somewhat
different research strategies may be important. For
dosimetry, astable compartmentthatreflects accumu-
lation oflead over time is important; for mobilization,
it is important to be able to measure lead in unstable
compartments ofmineral tissue and to be able to esti-
mate rates ofbone formation/absorption at the same
time.
The field of lead toxicology may be transformed by
the availability ofnew technology for measuring lead
stores inbone, the majorpoolforlead inthebody. Bone
lead may prove to be a vast improvement in dosimetry
and, as such, advance our understanding ofthe dose-
responserelationships ofleadatlowdose andthe long-
term consequences of low level lead exposure. That
there are children with veryhighbone lead stores sug-
gests that they may be persons at considerable risk of
lead toxicity whose risk is not adequately assessed by
measurementsofbloodleadlevelsorchelatable leadin
urine (45).
In certainpopulations at risk forbone demineraliza-
tion for reasons ofnormal physiological change, aging,
or disease, it maybe important to determinebone lead
stores as a determinant of potential risk of toxicity
from mobilized lead during these periods. However, it
is clear that much needs to be known about mineral
metabolism and bone physiology during such periods
as pregnancy andlactation in order to evaluate the po-
tential risk of lead stored in bone for such persons.
In addition, the possibility that lead may affect the
endocrinological signals regulating mineral metabo-
lism andbone cell function requires further investiga-
tion, as suggested by Pounds (46). It may be that bone
cells containing lead respond differently to the hor-
monal signals accompanying pregnancy, lactation,
and menopause, which appear to be the determinants
of altered bone status. We have suggested that lead
may enhance processes ofdemineralizationby inhibit-
ing activation of vitamin D, decreasing calcium ab-
sorption, and interfering with hormonal signals, such
as prolactin (17). Finally, these studies may at last
focus attention upon bone as a target for lead toxicity.
It has been remarkable that this compartment, in
whichtheoverwhelming majority oflead isstored, has
longbeen considered as an inertdepot intowhich lead
is transferred and in which no biological response to
thisverytoxic element wasthought to occur. Advances
in mineralized tissue physiology, not least the finding
that most hormones that regulate bone cell status are
shared by, among other organs, the brain (47), should
serve to direct research toward understanding the en-
docrinological effects of lead and the cellular conse-
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quences oflead in bone for bone itselfand for the con-
trol of mineral flux that is regulated by bone. It has
been proposed that lead-calcium interactions are the
fundamental molecular mode of lead toxicity (41,48),
yet little attention has been paid to that physiological
systemwiththe highest concentrations ofcalcium and
lead and its interactions with such major functions as
growth, development, reproduction, and senescence.
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